heball

Genentech Overtakes Pfizer - Briefly

Apples and Oranges, with the state of the economy, growth stocks are out of the question in my portfolio. (The larger they are the harder they fall.) Given DNA fails to offer Divs, my vote of confidence goes to PFE @ $1.28/(10.40%), perhaps the additional income is not sustainable in the near future, but they're here today. A no brainer.